Loading...
•
Sep 30, 2021
Cronos Q3 2021 Earnings Report
Announced strategic realignment to support future growth strategies and reported an increase in consolidated net revenue.
Key Takeaways
Cronos Group's Q3 2021 saw a significant increase in consolidated net revenue, driven by growth in the adult-use market in Canada, increased sales in the Israeli medical cannabis market, and increased sales in the U.S. segment. The company is realigning its business to focus on brands, centralizing functions, and prioritizing investments in innovation.
Consolidated net revenue increased by 80% compared to Q3 2020.
Launched Cronos Group's first cultured cannabinoid gummy and vape products under Spinach FEELZ™ brand.
Spinach® held a double-digit market share in the gummies category in Canada.
Strategic realignment is expected to deliver $20 to $25 million in savings across operating expense categories in 2022.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The overall strategic realignment initiative is expected to deliver $20 to $25 million in initially identified savings across operating expense categories in 2022, primarily driven by savings in sales and marketing, general and administrative, and research and development.
Positive Outlook
- Centralizing functions under common leadership to increase efficient distribution of resources.
- Improving strategic alignment and eliminate duplicative roles and costs.
- Evaluating the Company's global supply chain and performing product reviews.
- Optimizing pricing and distribution in order to reduce fixed expenses and reduce complexity.
- Implementing an operating expense target to optimize cash deployment for activities such as margin accretive innovation and U.S. adult-use market entry.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...